Liabilities and Equity of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
LakeShore Biopharma Co., Ltd. quarterly Liabilities and Equity in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Liabilities and Equity for the quarter ending 31 Mar 2025 was $190,530,106, a 11% decline year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Liabilities and Equity in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Liabilities and Equity for the quarter ending 31 Mar 2025 was ¥1,367,663,211, a 9.6% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)
Liabilities and Equity, Quarterly (CNY)
Liabilities and Equity, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $190,530,106 -$22,722,517 -11% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $213,252,623 -$37,013,485 -15% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 $250,266,108 31 Mar 2023 20-F 26 Jul 2023 2023 FY

LakeShore Biopharma Co., Ltd. Quarterly Liabilities and Equity (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥1,367,663,211 -¥145,364,145 -9.6% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥1,513,027,356 -¥206,726,255 -12% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q1 2023 ¥1,719,753,611 +¥278,000,470 +19% 31 Mar 2023 20-F 15 Aug 2024 2024 FY
Q1 2022 ¥1,441,753,141 31 Mar 2022 20-F 26 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.